GenieBiome Limited 精進微生物科技有限公司
Rachel Fan is the current Chief Executive Officer at GenieBiome Limited, where Rachel has been employed since June 2020. Prior to their current role, Rachel worked at GeneDecode Company Limited as the Managing Director. With a background in the healthcare industry, Rachel also held positions at GSK and GlaxoSmithKline in various directorial roles. Rachel's expertise lies in genetic analysis for personalized health management and personal growth services.
This person is not in any offices
GenieBiome Limited 精進微生物科技有限公司
G-NiiB® is the registered trademark of GenieBiome Limited. GenieBiome, a biotechnology spinout from The Chinese University of Hong Kong was founded by world-renowned clinician-scientists and supported by a multidisciplinary team of experts in microbiology, metagenomics, bioinformatics, disease biomarkers, food technology, clinical trials, IP development and commercialization. For over a decade, our team has pioneered the use of microbiome with evidence-based science to tackle a myriad of diseases, including COVID-19, colorectal cancer, obesity, eczema, and autism. Our precision portfolio of G-NiiB includes diagnostic and risk prediction tests, next-generation microbiome precision formula, and precision medicine tailored for the Asian population. ------------ G-NiiB® 是精進微生物科技有限公司 GenieBiome Ltd 及其子公司的註冊商標。 G-NiiB 是一家由香港中文大學衍生出來的生物科技公司，由世界知名的臨床醫生科學家創立，並由微生物學，宏基因組學，生物信息學，疾病生物標誌物，食品技術，臨床試驗，知識產權開發和商業策略的多學科專家團隊提供支持。十多年來，我們團隊率先從科學論證微生物群的應用，以應對多種疾病，包括COVID-19，結直腸癌，肥胖，濕疹和自閉症。我們的精準微生態診斷及風險測試、精準微生態平衡配方、新一代天然活菌及治療，專為亞洲人而設。